New heart valve device aims to fix leaky tricuspid valve without open surgery
Disease control
Recruiting now
This early study tests a new device called the Laplace Transcatheter Tricuspid Valve Replacement System. It is for people aged 60-90 with severe tricuspid regurgitation (a leaky heart valve) who still have symptoms despite medication. The goal is to see if the device can be safel…
Phase: NA • Sponsor: Laplace Interventional, Inc • Aim: Disease control
Last updated May 26, 2026 12:09 UTC